June 30, 2026

Via Edgar

Ms. Jessica Dickerson

Division of Corporation Finance

Office of Life Sciences

U.S. Securities and Exchange Commission

Washington, D.C. 20549

	Re:	Creative Medical Technology Holdings, Inc.
		Request for Withdrawal of Registration Statement on Form S-1
		Filed June 25, 2026
		File No. 333-297026

Dear Ms. Dickerson:

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Creative Medical Technology Holdings, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement be withdrawn, effective as of the date hereof. The Company is withdrawing the Registration Statement because it no longer plans to consummate the offering of its securities described in the Registration Statement. The Registration Statement has not been declared effective by the Securities and Exchange Commission (the “SEC”), and no securities have been issued or sold thereunder. Accordingly, the Company believes that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors.

The Company requests that, in accordance with Rule 457(p) of the Securities Act and subject to compliance with the requirements thereof, all fees paid to the SEC in connection with the filing of the Registration Statement be credited for future use.

Please contact Zev M. Bomrind of Pachulski Stang Ziehl & Jones LLP, counsel to the Company, at (646) 483-5497, if you have any other questions or concerns regarding this matter.

		Sincerely,
		/s/ Timothy Warbington
		Timothy Warbington
		Chief Executive Officer